Emergent BioSolutions Inc. — Director's Dealing 2020

Mar 6, 2020

SEC Form 3/A — Form 3/A

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2020-03-05

Reporting Person: Kirk Sean (EVP, Manufacturing & Tech Ops)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	12180	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Options (Right to Buy)	$50.52	2026-03-31	Common Stock (5696.0)		Direct

Footnotes

F1: Consists of 2,933 shares, 1,424 unvested PSUs and 7,823 unvested RSUs granted from the Emergent Stock Incentive Plan. Each RSU and each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period. The RSUs vest in three equal installments annually on the day prior to the anniversary date of the grant.

F2: The share amount reported herein has been amended to reflect a corrected share total from the form 3 filed on June 3, 2019.

F3: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.